Professor Of Medicine
Gastroenterology
Dr. James M. Scheiman, MD
|
|
Give Review
James M. Scheiman, MD is an expert in the field of Gastroenterology. He went to University of Michigan Medical School. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (AGAF)" and "Fellow (FACG)". James Scheiman is also a published doctor. He has 74 paper published. The most recent paper is: Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers. Doctor James M. Scheiman, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- "Risky business": periprocedural aspirin use for colonoscopy with polypectomy.
- NSAID-induced GastroIntestinal Injury: A Focused Update for Clinicians.
- Predicting the likelihood of a persistent bile duct stone in patients with suspected choledocholithiasis: accuracy of existing guidelines and the impact of laboratory ...
- Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review.
- The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
- Transpapillary Gallbladder Stents can Stabilize or Improve Decompensated Cirrhosis in Patients Awaiting Liver Transplantation.
- Variation in Aptitude of Trainees in Endoscopic Ultrasonography, Based on Cumulative Sum Analysis.
- Endoscopic Transpapillary Gallbladder Stent Placement Is Safe and Effective in High-Risk Patients Without Cirrhosis.
- Secretin-Stimulated MRCP to Optimally Select Patients for Pancreatic Endotherapy?
- Effect of a Health System's Medical Error Disclosure Program on Gastroenterology-Related Claims Rates and Costs.
- Through-the-skin ERCP and endoscopic ultrasound-guided cystogastrostomy in a patient with a Roux-en-Y Gastric bypass.
- In vivo optical spectroscopy for improved detection of pancreatic adenocarcinoma: a feasibility study.
- Long-term Follow-up of Asymptomatic Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type I Syndrome.
- Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care.
- Association between Helicobacter pylori and Barrett's Esophagus, erosive esophagitis, and gastroesophageal reflux symptoms.
- Associations of Diabetes Mellitus, Insulin, Leptin, and Ghrelin With Gastroesophageal Reflux and Barrett's Esophagus.
- Breast Cancer Metastases to the Pancreas.
- Growth of ambulatory surgical centers, surgery volume, and savings to medicare.
- Peritoneal Fluid Bilirubin to Serum Bilirubin Ratio for the Diagnosis of Bile Leaks in Orthotopic Liver Transplant Recipients.
- A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett's Esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
- Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oEsophagus.
- Prediction of Barrett's Esophagus Among Men.
- Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? Post hoc Efficacy and Cost-Benefit Analy...
- Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic Cancer patients undergoing neoadjuvant therapy.
- Esomeprazole for Prevention and Resolution of Upper GastroIntestinal Symptoms in Patients Treated With Low-dose Acetylsalicylic Acid for Cardiovascular Protection: the...
- Clinical yield of diagnostic ERCP in orthotopic liver transplant recipients with suspected Biliary complications.
- A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis.
- Prevention of damage induced by aspirin in the GI tract.
- EUS and pancreatic cyst fluid analysis: Is the juice worth the aqueeze?
- Erratum to: Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with GastroIntestinal Bleeding.
- Endoscopic Findings and Clinical Outcomes in Ventricular Assist Device Recipients with GastroIntestinal Bleeding.
- New diagnostic imaging modalities for pancreatic Disease.
- Endoscopic access to and exploration of the lesser sac in a human cadaver model: opportunity for transGastric endoscopic pancreatic surgery (with video).
- Esophageal adenocarcinoma incidence in individuals with gastroEsophageal reflux: synthesis and estimates from population studies.
- Which NSAID for your patient with osteoarthritis?
- AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk.
- Pancreatic cystic lesions.
- Reliable gene expression measurements from fine needle aspirates of pancreatic tumors: effect of amplicon length and quality assessment.
- Hydroperitoneum-facilitated EUS-guided peritoneal entry and closure of alternate access sites for NOTES.
- Strategies to optimize treatment with NSAIDs in patients at risk for gastroIntestinal and cardiovascular adverse events.
- Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
- PANDA cyst-fluid analysis: eats, shoots and leaves?
- Extending our scope to intramural lesions and beyond!
- Management of cystic lesions of the pancreas.
- Prevention of NSAID-Induced Ulcers.
- Updates on the management of upper gastrointestinal Disorders in the primary care setting: NSAID-related gastropathies and pediatric reflux diseases.
- Industry funding.
- New advances in pancreatic imaging.
- Prevention of Ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
- Computed tomography versus endoscopic ultrasonography for staging of pancreatic Cancer.
- Cystic lesion of the pancreas.
- Nonsteroidal anti-inflammatory drugs, aspirin, and gastroIntestinal prophylaxis: an ounce of prevention.
- Strategies to reduce the GI risks of antiplatelet therapy.
- Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States.
- Informed Choices in Anti-Inflammatory Drug Therapy: Why Patient Risk Matters.
- A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastroIntestinal mucosal injury.
- EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.
- EMR for early stage esophageal Cancer: setting the stage for improved patient outcomes.
- Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and Biliary disease prevalence on the economic comparison of alternative diagn...
- Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of Colorectal cancer: a cost-effectiveness analysis.
- Endoscopic ultrasound-guided fine needle aspiration of the pancreas. Diagnostic utility and accuracy.
- Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary Achalasia.
- Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer Disease in the United States.
- Suspected choledocholithiasis: EUS, magnetic resonance cholangiopancreatography, or intraoperative cholecystectomy?
- GastroIntestinal outcomes: evidence for risk reduction in patients using coxibs.
- Initial experience with an electronic radial array echoendoscope: randomized comparison with a mechanical sector scanning echoendoscope in humans.
- Prevention of recurrent variceal Bleeding: as easy as A.P.C.?
- Nonmucinous cystic pancreatic Neoplasms.
- NSAIDs without a prescription: over-the-counter access, under-counted risks.
- Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis.
- Outcomes studies of the gastroIntestinal safety of cyclooxygenase-2 inhibitors.
- Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
- Duct Diameter and Size of Stones Predict Successful Extracorporeal Shock Wave Lithotripsy and Endoscopic Clearance in Patients With Chronic Pancreatitis and Pancreatic...
Schools
University Of Michigan Medical School
University Mich Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Hemorrhoidectomy or Excision of Anal Tags
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (AGAF)
- Fellow (FACG)
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1053495101 | |
| NPPES Provider LastName | SCHEIMAN | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 481095362 | |
| NPPES Provider State | MI | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 83.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053495101 |
| Last Name Of The Provider | SCHEIMAN |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Allan W. Barbish, MD |
|
|
Dr. Michelle A. Anderson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Wiley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Y. Kao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shail M. Govani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mimi S. Takami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony T. Debenedet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chung Owyang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil M. Sheth, MD |
|
|
Dr. Anna S. Lok, MD
This Doctor is OpenDoctor Recommended.
|